(S)-(4-((5-Fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl)amino)phenyl)(3-(methylamino)pyrrolidin-1-yl)methanone

97%

  • Product Code: 126297
  CAS:    924641-59-8
Molecular Weight: 437.51 g./mol Molecular Formula: C23H28FN7O
EC Number: MDL Number: MFCD13184818
Melting Point: Boiling Point:
Density: Storage Condition: 2-8°C, protected from light, dry and sealed
Product Description: This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly as a targeted therapeutic agent. It is designed to inhibit specific protein kinases involved in signaling pathways that drive the growth and survival of cancer cells. By selectively binding to these kinases, it disrupts their activity, thereby halting the proliferation of malignant cells and inducing apoptosis. This makes it a promising candidate for the treatment of various cancers, especially those driven by mutations or overexpression of the targeted kinases. Additionally, its structure is optimized for enhanced bioavailability and reduced off-target effects, which is critical for minimizing adverse reactions in patients. Research is ongoing to explore its efficacy in preclinical and clinical settings, with potential applications in personalized medicine based on genetic profiles of tumors.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.005 10-20 days ฿25,940.00
+
-
(S)-(4-((5-Fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl)amino)phenyl)(3-(methylamino)pyrrolidin-1-yl)methanone
This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly as a targeted therapeutic agent. It is designed to inhibit specific protein kinases involved in signaling pathways that drive the growth and survival of cancer cells. By selectively binding to these kinases, it disrupts their activity, thereby halting the proliferation of malignant cells and inducing apoptosis. This makes it a promising candidate for the treatment of various cancers, especially those driven by mutations or overexpression of the targeted kinases. Additionally, its structure is optimized for enhanced bioavailability and reduced off-target effects, which is critical for minimizing adverse reactions in patients. Research is ongoing to explore its efficacy in preclinical and clinical settings, with potential applications in personalized medicine based on genetic profiles of tumors.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :